Elisa Caiola

838 total citations
33 papers, 621 citations indexed

About

Elisa Caiola is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Elisa Caiola has authored 33 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Elisa Caiola's work include Lung Cancer Treatments and Mutations (12 papers), DNA Repair Mechanisms (9 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Elisa Caiola is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), DNA Repair Mechanisms (9 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Elisa Caiola collaborates with scholars based in Italy, Greece and United States. Elisa Caiola's co-authors include Massimo Broggini, Mirko Marabese, Marina Chiara Garassino, Laura Brunelli, Roberta Pastorelli, Monica Ganzinelli, Eliana Rulli, Sheila Piva, Monica Lupi and Gabriella Farina and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Elisa Caiola

32 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Caiola Italy 15 450 227 208 164 78 33 621
Verónica Corrales‐Sánchez Spain 13 354 0.8× 169 0.7× 143 0.7× 105 0.6× 70 0.9× 25 497
Huawei Zou China 16 403 0.9× 244 1.1× 322 1.5× 163 1.0× 70 0.9× 36 710
Prabhjot S. Mundi United States 9 290 0.6× 175 0.8× 92 0.4× 111 0.7× 87 1.1× 27 490
Anchit Khanna Australia 10 512 1.1× 298 1.3× 92 0.4× 112 0.7× 58 0.7× 16 691
Christopher Moy United States 12 363 0.8× 270 1.2× 161 0.8× 177 1.1× 47 0.6× 17 618
Katharina Malinowsky Germany 17 389 0.9× 149 0.7× 177 0.9× 73 0.4× 51 0.7× 27 660
Elisabeth Llonch Switzerland 2 509 1.1× 214 0.9× 93 0.4× 128 0.8× 106 1.4× 2 651
Ruixia Huang Norway 15 374 0.8× 247 1.1× 215 1.0× 65 0.4× 49 0.6× 27 638
Zezhen Liu China 14 495 1.1× 108 0.5× 298 1.4× 200 1.2× 37 0.5× 26 681
Danian Dai China 15 448 1.0× 295 1.3× 398 1.9× 169 1.0× 46 0.6× 28 823

Countries citing papers authored by Elisa Caiola

Since Specialization
Citations

This map shows the geographic impact of Elisa Caiola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Caiola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Caiola more than expected).

Fields of papers citing papers by Elisa Caiola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Caiola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Caiola. The network helps show where Elisa Caiola may publish in the future.

Co-authorship network of co-authors of Elisa Caiola

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Caiola. A scholar is included among the top collaborators of Elisa Caiola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Caiola. Elisa Caiola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guffanti, Federica, Giulia Vargiu, Edoardo Micotti, et al.. (2024). Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring. Frontiers in Oncology. 14. 1504938–1504938.
2.
Corsetto, Paola Antonia, Angela Maria Rizzo, Mirko Marabese, et al.. (2022). NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2). Cells. 11(23). 3719–3719. 4 indexed citations
3.
Marabese, Mirko, et al.. (2022). LKB1: Can We Target an Hidden Target? Focus on NSCLC. Frontiers in Oncology. 12. 889826–889826. 14 indexed citations
4.
Ganzinelli, Monica, Helena Linardou, M.F. Alvisi, et al.. (2021). Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy. ESMO Open. 6(1). 100034–100034. 2 indexed citations
5.
Borzi, Cristina, Monica Ganzinelli, Elisa Caiola, et al.. (2021). LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress–Based Treatments. Journal of Thoracic Oncology. 16(8). 1298–1311. 16 indexed citations
6.
Guffanti, Federica, M.F. Alvisi, Elisa Caiola, et al.. (2020). Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts. Cancers. 12(9). 2398–2398. 9 indexed citations
7.
Marabese, Mirko, et al.. (2020). Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations. Frontiers in Oncology. 10. 532292–532292. 8 indexed citations
8.
Caiola, Elisa, Federica Guffanti, Edoardo Micotti, et al.. (2019). LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors. Journal of Thoracic Oncology. 15(3). 360–370. 27 indexed citations
9.
Caiola, Elisa, et al.. (2018). Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib. Scientific Reports. 8(1). 948–948. 24 indexed citations
10.
Caiola, Elisa, Francesca Falcetta, Silvia Giordano, et al.. (2018). Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach. Journal of Experimental & Clinical Cancer Research. 37(1). 302–302. 27 indexed citations
11.
Moro, Massimo, Elisa Caiola, Monica Ganzinelli, et al.. (2018). Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC. Journal of Thoracic Oncology. 13(11). 1692–1704. 80 indexed citations
12.
Marabese, Mirko, Elisa Caiola, Marina Chiara Garassino, et al.. (2016). G48A, a New KRAS Mutation Found in Lung Adenocarcinoma. Journal of Thoracic Oncology. 11(7). 1170–1175. 5 indexed citations
13.
Rulli, Eliana, Federica Guffanti, Elisa Caiola, et al.. (2016). The 5′UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs. Scientific Reports. 6(1). 39217–39217. 5 indexed citations
14.
Caiola, Elisa, et al.. (2016). Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX. Translational Oncology. 9(5). 458–465. 11 indexed citations
15.
Ganzinelli, Monica, Eliana Rulli, Elisa Caiola, et al.. (2015). Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR). Scientific Reports. 5(1). 16331–16331. 11 indexed citations
16.
Piva, Sheila, Monica Ganzinelli, Marina Chiara Garassino, et al.. (2014). Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer. Current Pharmaceutical Design. 20(24). 3933–3943. 27 indexed citations
17.
Caiola, Elisa, Massimo Broggini, & Mirko Marabese. (2014). Genetic markers for prediction of treatment outcomes in ovarian cancer. The Pharmacogenomics Journal. 14(5). 401–410. 16 indexed citations
18.
Caiola, Elisa, Eliana Rulli, Robert Fruscio, et al.. (2012). KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer.. PubMed Central. 10 indexed citations
19.
Caiola, Elisa, Luca Porcu, Robert Fruscio, et al.. (2011). DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer. The Pharmacogenomics Journal. 13(2). 159–172. 16 indexed citations
20.
Deitcher, Steven R., Elisa Caiola, & Amir K. Jaffer. (2000). Factor V Leiden and Prothrombin G20210A: Demystifying two common genetic predispositions to venous thrombosis. Cleveland Clinic Journal of Medicine. 67(11). 825–836. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verónica Corrales‐Sánchez Breakdown of academic impact, for papers by Huawei Zou Breakdown of academic impact, for papers by Prabhjot S. Mundi Breakdown of academic impact, for papers by Anchit Khanna Breakdown of academic impact, for papers by Christopher Moy Breakdown of academic impact, for papers by Katharina Malinowsky Breakdown of academic impact, for papers by Elisabeth Llonch Breakdown of academic impact, for papers by Ruixia Huang Breakdown of academic impact, for papers by Zezhen Liu Breakdown of academic impact, for papers by Danian Dai
Rankless by CCL
2026